High Concentration and Sustained Release Formulations
Our team has the expertise and capability in place to work on alternate formulation processes that can be handed off to the manufacturing team for scale-up. Since technology transfer and scale-up work can be performed under the same roof, Althea can be your timely and cost-effective solution for your drug development needs.
Protein Formulation Technology - Crystalomics™
Althea’s protein formulation technology platform, Crystalomics™, utilizes protein crystallization and complexation technology for the development of sustained release and high concentration formulations. The technology has already been proven in clinical trials through Phase II with a crystalline suspension of recombinant human growth hormone, while manufacturability has also been demonstrated by the well-established, cGMP manufacturing process at Althea.